Answer
Clomipramine hydrochloride is not recommended for depression, phobias or narcolepsy-associated cataplexy in children and adolescents aged 0–17 because evidence of its safety and efficacy for these indications is insufficient.
Sources for this answer
- Clomipramine 25 mg Capsules, HardViatris (formerly Mylan or Upjohn) · emc · SmPC §4.1 Therapeutic Indications · Version 2Document updated
Sources checked